why choose us

First received: November 07, 2022

Clinical Trial: Tazemetostat and Venetoclax in Relapsed/Refractory Non-Hodgkin Lymphoma

Study Status: Completed

Recruit Status: RECRUITING

Condition: Lymphoma, Non-Hodgkin

Study Type: INTERVENTIONAL


Official Title: Phase I Trial of Tazemetostat in Combination With Venetoclax in Patients With Relapsed/Refractory Non-Hodgkin Lymphoma

Brief Summary: The goal of this clinical trial is to learn about how a combination of tazemetostat and venetoclax in people with relapsed/refractory Non-Hodgkin Lymphoma (R/R NHL).The main questions that this trial aims to answer are what is the best dose of venetoclax to give with tazemetostat to people with R/R NHL; what types of side effects do people with R/R NHL get when taking venetoclax with tazemetostat; and what effects does this combination have on R/R NHL.Participants will need to take pills…

Read more